Tilray Brands Inc

Tilray Brands Inc(TLRY)股票分析

$3.210

+0.072 (+2.23%)收盘时

Loading chart…
最高
3.280
开盘
3.090
成交量加权均价
3.19
成交量
2.67M
市值
1.43B
最低
3.070
成交额
8.51M
企业价值/息税折旧摊销前利润(TTM)
135.76

Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. It also owns digital healthcare and patient engagement platform, focused on medical cannabis education, physician consultations, and patient support services.

AI 分析 of Tilray Brands Inc (TLRY)

卖出

Tilray Brands Inc is not a good buy right now due to significant financial losses and declining stock performance. The current price is $3.54, and the stock has dropped 63.58% year-to-date. Additionally, the RSI is at 26.854, indicating it is oversold, but this does not guarantee a price recovery in the near term.

分析师评级(3)

上行空间 +198.13%
买入
3 买入
0 持有
0 卖出
当前: 3.21
最低
8.50
平均
9.57
最高
10.00

TD Cowen

2026-07-14

目标价

$5

买入

Canaccord

2026-04-02

目标价

$13

持有

Roth Capital

2026-04-01

目标价

$10

买入

Alliance Global

2026-04-01

目标价

$7

中性

TD Cowen

2026-03-30

目标价

$7

买入

估值指标

Tilray Brands Inc(TLRY)当前预期市盈率为 1000.00,5 年平均预期市盈率为 153.23。

预期市盈率

严重高估
5 年均值 P/E
153.23
当前P/E
1000.00
高估
550.22
低估
-243.75

预期 EV/EBITDA

严重高估
5 年均值 EV/EBITDA
24.73
当前EV/EBITDA
135.76
高估
46.30
低估
3.16

预期市销率

低估
5 年均值 P/S
2.14
当前P/S
0.42
高估
3.83
低估
0.44

Alphio AI 对 TLRY 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%TLRY

$0.55

情景价格

基

基准

基准 · 50%TLRY

$0.49

情景价格

悲

悲观

悲观 · 25%TLRY

$0.44

情景价格

事件时间线

2026-10-08 (ET)

16:30:00

Major Averages Decline Amid Rising Oil Prices

12:30:00

Major Averages Decline as Oil Prices Surge

09:00:00

Stock Futures Lower as Oil Prices and Treasury Yields Rise

07:30:00

Tilray Brands Reports Q1 Revenue of $257.15M

07:30:00

Company Reaffirms FY2027 Adjusted EBITDA Expectation of $68M to $75M

资讯

TLRY 常见问题 —— 由 Alphio AI 解答

Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. It also owns digital healthcare and patient engagement platform, focused on medical cannabis education, physician consultations, and patient support services. It operates in the Healthcare sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Tilray Brands Inc is not a good buy right now due to significant financial losses and declining stock performance. The current price is $3.54, and the stock has dropped 63.58% year-to-date. Additionally, the RSI is at 26.854, indicating it is oversold, but this does not guarantee a price recovery in the near term.

3 analysts cover TLRY: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 9.57.

$TLRY is moving forward with its strategic transformation. From expanding its diversified portfolio to improving operational efficiencies and pursuing new growth opportunities, Tilray Brands is laying the groundwork for a stronger future. Can these strategic moves support sustainable growth and drive the stock's next rally? What's your take?

展开
lunarviper2026/9/24

🚀 $TLRY is moving into its next growth phase with a diversified push across cannabis, beverages, hospitality and wellness. 🌿🍺 Management is targeting $68M-75M in FY27 adjusted EBITDA, while BrewDog integration, international cannabis expansion and brand scaling remain key priorities. 💰 Tilray ended FY26 with about $235M in cash and securities and just $0.7M in net debt, giving it financial flexibility to keep investing in growth. 📈🔥

展开
注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易